Here are five insights:
1. This new technology is planned for use in orthopedics, including spinal and trauma applications.
2. Columbia-based University of Missouri researchers developed this technology.
3. This new technology will become part of Prosidyan’s FIBERGRAFT bone graft line.
4. Presently, physicians have implanted FIBERGRAFT products in more than 4,000 U.S. patients.
5. Prosidyan develops proprietary fiber-based bioactive glass orthobiologics products.
More articles on devices and implants:
Amendia, Benvenue Medical, Zimmer Biomet & more: 15 key notes
Amendia names Chris Fair CEO: 4 points
Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
